AWA
CVS icon

Amplius Wealth Advisors’s CVS Health CVS Stock Holding History

Amplius Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,805
Closed -$224K – 172
2024
Q1 		$224K Sell
2,805
-38
-1% -$2.9K 0.03% 157
2023
Q4 		$224K Buy
+2,843
New +$202K 0.03% 158
2023
Q2 		– Sell
-2,723
Closed -$202K – 169
2023
Q1 		$202K Buy
2,723
+38
+1% +$3.19K 0.03% 154
2022
Q4 		$250K Sell
2,685
-315
-11% -$30.4K 0.04% 132
2022
Q3 		$286K Buy
3,000
+32
+1% +$3.17K 0.05% 121
2022
Q2 		$275K Sell
2,968
-148
-5% -$14.4K 0.04% 133
2022
Q1 		$315K Buy
3,116
+5
+0.2% +$525 0.05% 129
2021
Q4 		$320K Buy
+3,111
New +$287K 0.04% 149

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Amplius Wealth Advisors's CVS Position: Q2 2024 in Review

Amplius Wealth Advisors sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,805 shares — an estimated $224K sold.

Amplius Wealth Advisors first reported a position in CVS in Q4 2021 and held it in 8 quarters. The position peaked at $320K in Q4 2021. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Amplius Wealth Advisors reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Amplius Wealth Advisors sold 2,805 CVS Health shares in Q2 2024, an estimated $224K.
  • Amplius Wealth Advisors first reported a position in CVS Health in Q4 2021 and held it in 8 quarters.
  • Amplius Wealth Advisors's CVS Health position peaked at $320K in Q4 2021.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Amplius Wealth Advisors's 13F filing for Q2 2024, filed 22 Jul 2024.